Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
Patent Number: 6875430
Date of First Priority Issue: Wednesday March 18th, 1998
Date Issued: Tuesday April 5th, 2005
Assignee: Osiris Therapeutics, Inc. (Baltimore, MD)
Inventors: McIntosh, Kevin R. (Ellicott City, MD); Mosca, Joseph D. (Ellicott City, MD); Klyushnenkova, Elena (Baltimore, MD)
From Class: Use
Comments: No comments
Xenotransplantation is limited primarily by antibody mediated rejection. Accordingly while this patent covers the use of mesenchymal stem cells for preventing xenograft rejection, the actual applicability of this patent seems unlikely since mesenchymal stem cells do not strongly protect against antibody mediated immune rejection in xenotransplantation.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.